- Fiscal 2019 Revenue of
$626.3 million - Fiscal 2019 Adjusted EBITDA of
$23.9 million - Fiscal 2019 Free Cash Flow of
$1.0 million , an improvement of$20.4 million from 2018
Fiscal 2019 Results
- Revenue was
$626.3 million for the fiscal year endedDecember 28, 2019 , as compared to$673.5 million in fiscal 2018, representing a decrease of 7.0%. Fiscal fourth quarter 2019 revenue of$91.0 million was down 20.6% compared to the prior year period; however, the impact of prior year fulfillment center issues resulted in delaying over$10.0 million of shipments from Q3 into Q4 2018. With the strong operational performance in 2019, the fourth quarter of 2019 did not experience a shift in shipment timing. Weaker orders in November and December also contributed to the year-over-year revenue decreases in Q4 2019 across all product categories. A portion of the revenue decline experienced in the fiscal year and the fourth quarter can be attributed to decisions not to pursue certain large, low-margin Supply and Furniture revenue opportunities.
- The Company reported a gross profit margin for the year ended
December 28, 2019 of 33.2% as compared to 33.9% reported in 2018. Fourth quarter 2019 gross profit margin was 32.5% compared to 31.5% in the prior year period.- We have seen consistent improvement in year-over-year gross margin trends throughout fiscal 2019, particularly in our Supplies and Furniture product categories. Supplies gross margin was up approximately 50 bps YOY for full year 2019 and up 350 bps YOY in the fourth quarter of 2019 compared to the prior year’s fourth quarter. Furniture gross margin was up approximately 110 bps for full year 2019 and up 230 bps in Q4 2019.
- We have seen consistent improvement in year-over-year gross margin trends throughout fiscal 2019, particularly in our Supplies and Furniture product categories. Supplies gross margin was up approximately 50 bps YOY for full year 2019 and up 350 bps YOY in the fourth quarter of 2019 compared to the prior year’s fourth quarter. Furniture gross margin was up approximately 110 bps for full year 2019 and up 230 bps in Q4 2019.
- Selling, general and administration (“SG&A”) expenses were
$217.9 million for the year endedDecember 28, 2019 , which represents a$4.2 million decrease year-over-year. Excluding incremental restructuring costs in SG&A, SG&A expenses declined by$14.3 million year-over-year, reflecting a continued focus on lowering fixed expenses throughout the Company. SG&A for the fiscal fourth quarter 2019 of$50.5 million was down$1.1 million , or 2.2% below the comparable prior year period. Excluding incremental fourth quarter restructuring costs in SG&A, SG&A expenses declined by$5.7 million , or 11.2%, compared to the fourth quarter of 2018.
- The Company reported adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) of approximately
$23.9 million for the year endedDecember 28, 2019 compared to$35.1 million in the year endedDecember 29, 2018 . Approximately$7.3 million of the decrease related to our Agendas product category. The Agendas product category generated negative EBITDA of approximately$5.3 million in 2019 and the Company exited the product line at the end of 2019. Fourth quarter Adjusted EBITDA in 2019 was -$9.9 million as compared to-$8.4 million in the prior year fourth quarter.
- Free cash flow in 2019 was
$1.0 million as compared to-$19.4 million in 2018. The successful normalization of working capital provided$18.0 million of positive cash flow impact in 2019 as compared to working capital providing a negative cash flow impact of$17.8 million in 2018. Reduced capital expenditures and product development expenditures contributed an additional$3.8 million free cash flow improvement. These year-over-year improvements to free cash flow were partially offset by$11.2 million of lower EBITDA in 2019,$10.2 million of incremental restructuring and restructuring-related costs and$2.2 million of incremental cash interest in 2019.
Conference Call Information
Toll-free number: 844-882-7832 / International number: 574-990-9706 / Conference ID: 3570768
Replay number: 855-859-2056 / International replay number: 404-537-3406 / Conference ID: 3570768
Interested parties can also participate on the webcast by visiting the Investor Relations section of School Specialty’s website at http://investors.schoolspecialty.com. For those who are unable to participate on the live conference call and webcast, a replay will be available approximately one hour after the completion of the call.
About
Statement Concerning Forward-Looking Information
Any statements made in this press release about School Specialty’s future financial condition, results of operations, expectations, plans, or prospects the information regarding our Fiscal 2019 financial performance and business objectives outlook, constitute forward-looking statements. Forward-looking statements also include those preceded or followed by the words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," “projects,” “should,” "targets" and/or similar expressions. These forward-looking statements are based on
Non-GAAP Financial Information
This press release includes references to Adjusted EBITDA, a non-GAAP financial measure. Adjusted EBITDA represents net income (loss) adjusted for: provision for (benefit from) income taxes; purchase accounting deferred revenue adjustments; restructuring costs; restructuring-related costs included in SG&A; impairment charges; depreciation and amortization expense; amortization of development costs; net interest expense; and stock-based compensation. Free Cash Flow represents Adjusted EBITDA adjusted for: capital expenditures; product development expenditures; proceeds from asset sales; unrealized foreign exchange gains and losses; other; changes in working capital; Cash Interest and Cash Taxes.
The Company considers Adjusted EBITDA a relevant supplemental measure of its financial performance and Free Cash Flow a relevant supplemental measure of liquidity. The Company believes these non-GAAP financial measures provide useful supplemental information for investors regarding trends and performance of our ongoing operations and is useful for year-over-year comparisons of such results. We also use these non-GAAP financial measures in making operational and financial decisions and in establishing operational goals.
In summary, we believe that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, helps investors to (i) evaluate our operating and financial performance and future prospects, (ii) compare financial results across accounting periods, (iii) better understand the long-term performance of our core business, (iv) evaluate trends in our business, (v) evaluate our ability to generate cash and improve liquidity, and (vi) assess the Company’s ability to fund both its operating activities and reinvestments into the business, as well as service its debt, including debt repayments, all consistent with how management evaluates such performance and trends.
Adjusted EBITDA and Free Cash Flow do not represent, and should not be considered, an alternative to net income or operating income, or an alternative to cashflow from operations, as determined by GAAP, and our calculation may not be comparable to similarly titled measures reported by other companies.
Company Contacts | |
Ryan.bohr@schoolspecialty.com Tel: 920-882-5868 | Kevin.baehler@sch Tel: 920-882-5882 |
Investor and Media Relations Contact Mark.barbalato@fticonsulting.com Tel: 212-850-5707 | |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) | ||||||||
(In Thousands, Except Share and Per Share Amounts) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 2,077 | $ | 1,030 | ||||
Accounts receivable, less allowance for doubtful accounts | 61,718 | 77,888 | ||||||
Inventories, net | 71,424 | 90,061 | ||||||
Prepaid expenses and other current assets | 17,956 | 15,763 | ||||||
Refundable income taxes | 431 | 1,019 | ||||||
Total current assets | 153,606 | 185,761 | ||||||
Property, plant and equipment, net | 27,429 | 31,902 | ||||||
Operating lease right-of-use asset | 14,768 | - | ||||||
Goodwill | - | 4,580 | ||||||
Intangible assets, net | 24,733 | 33,306 | ||||||
Development costs and other | 13,740 | 14,807 | ||||||
Deferred taxes long-term | 466 | 320 | ||||||
Total assets | $ | 234,742 | $ | 270,676 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Current maturities - long-term debt | $ | 145,194 | $ | 30,352 | ||||
Current operating lease liability | 4,886 | - | ||||||
Accounts payable | 24,011 | 41,277 | ||||||
Accrued compensation | 8,929 | 7,302 | ||||||
Contract liabilities | 7,006 | 5,641 | ||||||
Accrued royalties | 1,992 | 2,678 | ||||||
Other accrued liabilities | 13,439 | 11,379 | ||||||
Total current liabilities | 205,457 | 98,629 | ||||||
Long-term debt - less current maturities | - | 103,583 | ||||||
Operating lease liability | 10,008 | - | ||||||
Other liabilities | 493 | 1,101 | ||||||
Total liabilities | 215,958 | 203,313 | ||||||
Stockholders' equity: | ||||||||
Preferred stock, | - | - | ||||||
Common stock, | 7 | 7 | ||||||
Capital in excess of par value | 125,793 | 125,072 | ||||||
(34 | ) | - | ||||||
Accumulated other comprehensive loss | (1,797 | ) | (2,079 | ) | ||||
Accumulated deficit | (105,185 | ) | (55,637 | ) | ||||
Total stockholders' equity | 18,784 | 67,363 | ||||||
Total liabilities and stockholders' equity | $ | 234,742 | $ | 270,676 | ||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(In Thousands, Except Per Share Amounts) | ||||||||||||||||
For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Revenues | $ | 91,020 | $ | 114,613 | $ | 626,073 | $ | 673,452 | ||||||||
Cost of revenues | 61,471 | 78,467 | 418,475 | 444,937 | ||||||||||||
Gross profit | 29,549 | 36,146 | 207,598 | 228,515 | ||||||||||||
Selling, general and administrative expenses | 50,505 | 51,615 | 217,921 | 222,168 | ||||||||||||
Impairment charge | - | 22,262 | 4,863 | 22,262 | ||||||||||||
Facility exit costs and restructuring | 391 | 1,314 | 2,681 | 2,463 | ||||||||||||
Loss on asset sold | 4,089 | - | 4,089 | - | ||||||||||||
Operating income (loss) | (25,436 | ) | (39,045 | ) | (21,956 | ) | (18,378 | ) | ||||||||
Other expense: | ||||||||||||||||
Interest expense | 5,591 | 4,197 | 20,519 | 15,548 | ||||||||||||
Loss on early extinguishment of debt | 8,032 | - | 8,032 | - | ||||||||||||
Change in fair value of derivatives | (1,238 | ) | - | 82 | - | |||||||||||
Income (loss) before benefit from income taxes | (37,821 | ) | (43,242 | ) | (50,589 | ) | (33,926 | ) | ||||||||
Provision for (benefit from) income taxes | (1,240 | ) | (4,605 | ) | (1,041 | ) | 4,815 | |||||||||
Net income (loss) | $ | (36,581 | ) | $ | (38,637 | ) | $ | (49,548 | ) | $ | (38,741 | ) | ||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 7,025 | 7,000 | 7,016 | 7,000 | ||||||||||||
Diluted | 7,025 | 7,000 | 7,016 | 7,000 | ||||||||||||
Net Loss per Share: | ||||||||||||||||
Basic | $ | (5.21 | ) | $ | (5.52 | ) | $ | (7.06 | ) | $ | (5.53 | ) | ||||
Diluted | $ | (5.21 | ) | $ | (5.52 | ) | $ | (7.06 | ) | $ | (5.53 | ) | ||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Adjusted Earnings before interest, taxes, depreciation, amortization, change in value of derivatives, restructuring and impairment charges (EBITDA) reconciliation: | ||||||||||||||||
Net income (loss) | $ | (36,581 | ) | $ | (38,637 | ) | $ | (49,548 | ) | $ | (38,741 | ) | ||||
Provision for (benefit from) income taxes | (1,240 | ) | (4,605 | ) | (1,041 | ) | 4,815 | |||||||||
Purchase accounting deferred revenue adjustment | - | 17 | - | 732 | ||||||||||||
Loss on early extinguishment of debt | 8,032 | - | 8,032 | - | ||||||||||||
Loss on asset sold | 4,089 | - | 4,089 | - | ||||||||||||
Impairment charge | - | 22,262 | 4,863 | 22,262 | ||||||||||||
Restructuring costs | 391 | 1,314 | 2,681 | 2,463 | ||||||||||||
Restructuring-related costs incl in SG&A | 5,085 | 456 | 12,468 | 2,458 | ||||||||||||
Change in fair value of derivatives | (1,238 | ) | - | 82 | - | |||||||||||
Depreciation and amortization expense | 4,797 | 4,310 | 17,915 | 17,917 | ||||||||||||
Amortization of development costs | 994 | 1,412 | 4,465 | 5,602 | ||||||||||||
Net interest expense | 5,591 | 4,197 | 20,519 | 15,548 | ||||||||||||
Stock-based compensation | 182 | 842 | (589 | ) | 2,020 | |||||||||||
Adjusted EBITDA | $ | (9,898 | ) | $ | (8,432 | ) | $ | 23,936 | $ | 35,076 | ||||||
Source:
2020 GlobeNewswire, Inc., source